Medical Bulletin 30/September/2023 Isra Zaman30 Sept 2023 3:15 PM ISTHere are the top medical news of the day:Atopic Dermatitis linked to increased risk of Inflammatory Bowel Disease, study findsIn a recent cohort...
Atopic Dermatitis linked to increased risk of Inflammatory Bowel Disease, study finds Isra Zaman30 Sept 2023 9:00 AM ISTIn a recent cohort study, researchers have uncovered a significant association between atopic dermatitis (AD) and the development of inflammatory...
Sanofi gets CDSCO panel nod to study atopic dermatitis drug Amlitelimab Dr. Divya Colin27 Sept 2023 6:00 PM ISTNew Delhi: The drug major Sanofi has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Atopic Dermatitis: Ultraviolet B phototherapy not tied to increased risk of skin cancer Medha Baranwal22 Sept 2023 9:30 AM ISTTaiwan: A recent population-based retrospective cohort study found no association between ultraviolet B phototherapy and an increased skin cancer risk...
Ciclosporin and methotrexate effective for treating children and young people with severe atopic dermatitis: Clinical trial Dr. Kamal Kant Kohli21 Sept 2023 10:00 AM ISTUK: A recent study comparing the efficacy and safety of ciclosporin with methotrexate in children and young people with severe atopic dermatitis has...
Which are most effective topical treatments of Atopic dermatitis? Medha Baranwal11 Sept 2023 9:30 AM ISTCanada: A systematic review and meta-analysis have shed light on the most effective topical treatments for atopic dermatitis (eczema). The findings...
Early emollient bathing closely associated with Atopic Dermatitis risk Jacinthlyn Sylvia3 Sept 2023 8:00 PM ISTRecent research has focused on the role of the skin barrier in the pathogenesis of Atopic dermatitis (AD), a chronic inflammatory skin condition, and...
Dupilumab significantly improves sleep quality and other signs and symptoms in atopic dermatitis patients Dr. Shravani Dali28 Aug 2023 10:00 AM ISTDupilumab significantly improves sleep quality and other signs and symptoms in atopic dermatitis patients suggests a new study published in the...
Long-term treatment with abrocitinib safe and effective for patients with moderate-to-severe atopic dermatitis Dr. Kamal Kant Kohli7 Aug 2023 10:15 AM ISTGermany: Findings from the long-term extension JADE EXTEND study supported Abrocitinib as an effective treatment for patients with moderate-to-severe...
Lebrikizumab promising maintenance therapy for atopic dermatitis Dr. Kamal Kant Kohli25 July 2023 11:45 AM ISTUSA: A recent study has shown promising results for lebrikizumab in the maintenance treatment of moderate-to-severe atopic dermatitis (AD).The study,...
Incidence of Osteoarthritis higher among patients of atopic dermatitis and asthma Aditi20 July 2023 6:00 PM ISTAccording to a study published in Annals of the Rheumatic Diseases, researchers have highlighted the incidence of Osteoarthritis to be higher in...
Sanofi Dupixent gets nod in India for treatment of adults with moderate-to-severe atopic dermatitis Ruchika Sharma11 July 2023 1:12 PM ISTDupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement.
